(Brussels:ARGX),(NASDAQ:ARGX), August 19, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled “R&D Spotlight | Pioneering MuSK Biology with ARGX-119” on Tuesday, September 16, 2025, at 2:00pm ET. The webinar […]
(SWX:SANN), Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE(R) (vamorolone) in the United Arab Emirates, the Kingdom of Saudi Arabia, Kuwait, Oman and Bahrain, for the treatment of Duchenne muscular dystrophy (DMD) in patients four years of age
argenx to Host R&D Webinar Highlighting ARGX-119 on September 16, 2025 GlobeNewswire August 19, 2025 August 19, 2025 Amsterdam, the Netherlands – argenx (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced it will host a webinar, titled “R&D Spotlight | Pioneering
Santhera Secures Agreement with Uniphar for the Distribution of AGAMREE(R) (Vamorolone) in five GCC (Gulf Cooperation Council) Countries GlobeNewswire August 19, 2025 Pratteln, Switzerland, 19 August, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the signing of an exclusive agreement with Uniphar to manage the distribution of AGAMREE(R) (vamorolone) in the United Arab Emirates, the Kingdom
Sigma Debuts 200mm f/2 Super-Telephoto Sports Lens, Ultra-Wide 12mm f/1.4 Primes; First Look YouTube Video, Preorder and More Info at B&H GlobeNewswire August 19, 2025 Sigma is releasing the 200mm f/2 super-telephoto sports lens, new ultra-wide 12mm f/1.4 for APS-C prime lenses for full-frame mirrorless cameras. NEW YORK, Aug. 19, 2025 (GLOBE NEWSWIRE) — B&H
US Beauty Industry Grows in the First Half of 2025, Circana Reports GlobeNewswire August 19, 2025 CHICAGO, IL, Aug. 19, 2025 (GLOBE NEWSWIRE) — In the first half of 2025, the U.S. prestige beauty market grew by 2% to $16 billion, while sales at mass merchants increased 4% to $34.6 billion, according to Circana, LLC.
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that its in-house discovered CLDN18.2 ADC, ATG-022,was granted a Breakthrough Therapy designation by the Center for Drug Evaluation (CDE) of the National Medical Products
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that its in-house discovered CLDN18.2 ADC, ATG-022,was granted a Breakthrough Therapy designation by the Center for Drug Evaluation (CDE) of the National Medical Products
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that its in-house discovered CLDN18.2 ADC, ATG-022,was granted a Breakthrough Therapy designation by the Center for Drug Evaluation (CDE) of the National Medical Products
Antengene Corporation Limited (“Antengene”, SEHK: 6996.HK), a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for hematologic malignancies and solid tumors, today announced that its in-house discovered CLDN18.2 ADC, ATG-022,was granted a Breakthrough Therapy designation by the Center for Drug Evaluation (CDE) of the National Medical Products